Yuan-Feng Gong
Department of Hepatobiliary Surgery,
Affiliated Cancer Hospital,
Department of Hepatobiliary Surgery, Affiliated Cancer Hospital
Guangzhou Medical University
Yuan-Feng Gong has not added Biography.
If you are Yuan-Feng Gong and would like to personalize this page please email our Author Liaison for assistance.
The complete mitochondrial genome of malbrouck monkey, Chlorocebus cynosuros (Chlorocebus, Cercopithecinae).
Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis , 2016 | Pubmed ID: 25185937
The complete mitochondrial genome of Japanese macaque, Macaca fuscata fuscata (Macaca, Cercopithecinae).
Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis May, 2016 | Pubmed ID: 25242185
Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.
Journal of laparoendoscopic & advanced surgical techniques. Part A Jan, 2016 | Pubmed ID: 26779722
Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy.
Yonsei medical journal May, 2017 | Pubmed ID: 28332353
Optimized construction of MUC1-VNTR DNA vaccine and its anti-pancreatic cancer efficacy.
Oncology letters Apr, 2017 | Pubmed ID: 28454381
Mild hyperthermia enhances sensitivity of gastric cancer cells to chemotherapy through reactive oxygen species-induced autophagic death.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Jun, 2017 | Pubmed ID: 28639902
Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer.
Oncotarget Nov, 2017 | Pubmed ID: 29221147
Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
BMC cancer Aug, 2019 | Pubmed ID: 31462277
Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression.
OncoTargets and therapy , 2019 | Pubmed ID: 31496731
LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression.
Cell death & disease Jan, 2020 | Pubmed ID: 31988283
Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer.
Surgical laparoscopy, endoscopy & percutaneous techniques Feb, 2020 | Pubmed ID: 32004214
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Proceedings of the National Academy of Sciences of the United States of America 03, 2020 | Pubmed ID: 32123069
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Hepatology international Jul, 2020 | Pubmed ID: 32304089
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
World journal of gastroenterology May, 2020 | Pubmed ID: 32476795
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Science translational medicine 02, 2021 | Pubmed ID: 33536280
Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis.
Aging Jul, 2021 | Pubmed ID: 34226297
Should people with chronic liver diseases be vaccinated against COVID-19?
World journal of clinical cases Sep, 2021 | Pubmed ID: 34621852
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
Nature communications 12, 2021 | Pubmed ID: 34880251
Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma.
Frontiers in genetics , 2022 | Pubmed ID: 36186483
Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
Cheng-Yang Zhang*,1,2,
Xiao-Feng Zhang*,3,
Jun Yuan*,1,2,
Yuan-Feng Gong4,
Hui Tang4,
Wan-Yu Guo1,2,
Tong-Yan Li1,2,
Cai-Wen Li1,2,
Yun-Qiang Tang4,
Ning-Fang Ma1,2,
Ming Liu1,2
1, Affiliated Cancer Hospital and Institute of Guangzhou Medical University,
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University,
3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University,
4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。